AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30536185
Drug: Topical sodium
RxNorm normalized name: sodium fluoride .0176 g in 1 g / HYDROFLUORIC ACID 0.010 g in 1 g DENTAL AEROSOL, FOAM [DENTI-CARE TOPICAL SODIUM FLUORIDE STRAWBERRY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical sodium hyaluronate (SH) 0.18%
Trial: 25604134
Drug: Erlotinib 25
RxNorm normalized name: erlotinib 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 25 mg
Trial: 15359398
Drug: Preincisional wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preincisional wound infiltration of 3 mg/kg ropivacaine (Group I)
Trial: 15359398
Drug: Postincisional wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postincisional wound infiltration of 3 mg/kg ropivacaine (Group II)
Trial: 9709393
Drug: Chronic metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic metoprolol treatment
Trial: 7976801
Drug: dimethindene maleate
RxNorm normalized name: dimethindene maleate
DrugBank: Dimetindene (DB08801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dimethindene maleate (new 'once a day formulation')
Trial: 2596365
Drug: Gestoden triphasic
RxNorm normalized name: gestodene
DrugBank: Gestodene (DB06730)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestoden triphasic formulation
Trial: 2596365
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose combination pill containing desogrestrel
Trial: 2596365
Drug: Gestoden triphasic
RxNorm normalized name: gestodene
DrugBank: Gestodene (DB06730)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestoden triphasic formulation and Fixed dose combination pill containing desogrestrel
Trial: 5440571
Drug: Oral lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral lignocaine (500 mg taken with food)
Trial: 5440571
Drug: Oral lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral lignocaine (500 mg taken without food)
Trial: 5440571
Drug: Oral lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral lignocaine
Trial: 26448381
Drug: Oral alfacalcidol
RxNorm normalized name: alfacalcidol
DrugBank: Alfacalcidol (DB01436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral alfacalcidol therapy for 12 weeks
Trial: 18819792
Drug: Gemcitabine 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1250 mg/m(2) intravenous (i.v.) on days 1 and 8 of each 21‐day cycle
Trial: 14518352
Drug: Potassium and
RxNorm normalized name: Potassium and/or potassium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium and magnesium aspartate treatment for three weeks
Trial: 10090430
Drug: Eptifibatide (Integrilin)
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide (Integrilin) administered to patients undergoing coronary angioplasty; monitored for anti-eptifibatide antibodies at baseline and 30 days after treatment.
Trial: 10090430
Drug: Eptifibatide (Integrilin)
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide (Integrilin) administered to 28 healthy volunteers; 2 infusions 28 days apart, monitored at multiple time points (baseline, 28, 42, 56, 84, and 112 days).
Trial: 7672152
Drug: Single IM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single IM injection of 100 mg progestogen (group 1)
Trial: 7032947
Drug: Atenolol (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50, 100, and 200 mg)
Trial: 6585544
Drug: Topical steroidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroidal gel
Trial: 6585544
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel and capsules (Control)
Trial: 6585544
Drug: Sulindac (systemically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac (systemically administered nonsteroidal anti-inflammatory drug)
Trial: 30894009
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (dual-energy spectral imaging with reduced contrast dose at 0.3 gI/kg)
Trial: 30894009
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (conventional 120kVp scanning protocol with contrast dose at 0.6 gI/kg)
Trial: 24881806
Drug: Standard urotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard urotherapy treatment alone
Trial: 24881806
Drug: Standard urotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard urotherapy + TENS (in children without previous treatment)
Trial: 24881806
Drug: Standard urotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard urotherapy (in children without previous treatment)
Trial: 23043295
Drug: Garlic oil
RxNorm normalized name: Garlic Oil
DrugBank: Garlic oil (DB15989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic oil (0.005 mL/L) and ginger oil (0.005 mL/L) mixture
Trial: 23043295
Drug: Garlic oil
RxNorm normalized name: Garlic Oil
DrugBank: Garlic oil (DB15989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic oil (0.005 or 0.01 mL/L) and ginger oil (0.005 or 0.01 mL/L) mixture
Trial: 23043295
Drug: Garlic oil
RxNorm normalized name: Garlic Oil
DrugBank: Garlic oil (DB15989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic oil (0.02 mL/L)
Trial: 23043295
Drug: Ginger oil
RxNorm normalized name: Ginger oil
DrugBank: Ginger oil (DB14690)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger oil (0.01-0.02 mL/L)
Trial: 10089089
Drug: Piperacillin 12
RxNorm normalized name: PIPERACILLIN 12/TAZOBACTAM 1.5GM/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin 12 g/day plus tazobactam 1.5 g/day plus tobramycin 3 mg/kg per day
Trial: 10089089
Drug: Ceftazidime 3
RxNorm normalized name: ceftazidime 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 3 g/day plus tobramycin 3 mg/kg per day
Trial: 31044463
Drug: Low-dose aripiprazole
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aripiprazole (3 mg/day)
Trial: 31044463
Drug: High-dose aripiprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose aripiprazole (up to 12 mg/day)
Trial: 24096043
Drug: Dexmedetomidine (DEX)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (DEX) at low (1 μg/kg/hr) and high (3 μg/kg/hr) doses
Trial: 24096043
Drug: Propofol (PROP)
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol (PROP) at low (100 μg/kg/m) and high (200 μg/kg/m) doses
Trial: 21305525
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/m² (maximum 20 mg) once weekly for 12 months
Trial: 15155194
Drug: Anidulafungin 50
RxNorm normalized name: anidulafungin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anidulafungin 50 mg once daily
Trial: 15155194
Drug: Anidulafungin 75
RxNorm normalized name: Anidulafungin
DrugBank: Anidulafungin (DB00362)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anidulafungin 75 mg once daily
Trial: 15155194
Drug: Anidulafungin 100
RxNorm normalized name: anidulafungin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anidulafungin 100 mg once daily
Trial: 9988206
Drug: Grass pollen
RxNorm normalized name: grass pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass pollen extract in a hydroglyceric solution
Trial: 7751994
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms HB vaccine (Group A)
Trial: 7751994
Drug: 10 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms HB vaccine (Group B)
Trial: 7751994
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms HB vaccine (Group C)
Trial: 2077437
Drug: desglycinamide-(arg8) vasopressin
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: desglycinamide-(arg8) vasopressin (DGAVP) 2 mg, nasal route
Trial: 31498950
Drug: Aflibercept 2
RxNorm normalized name: ziv-aflibercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflibercept 2 mg administered as three loading doses every 4 weeks, then every 8 weeks until week 48
Trial: 25255447
Drug: LD-aminopterin (0.007,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LD-aminopterin (0.007, 0.014, 0.021 mg/kg once-weekly)
Trial: 25255447
Drug: LD-aminopterin (0.007
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LD-aminopterin (0.007 mg/kg twice-weekly)
Trial: 22696863
Drug: 0.1% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% timolol eye gel
Trial: 17393018
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone therapy (25 microg 17beta‐estradiol/125 microg norethisterone acetate applied every 3-4 days)
Trial: 17393018
Drug: Oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral hormone therapy (estradiol 1 mg and NETA 0.5 mg given once daily)
Trial: 7519693
Drug: Trandolapril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril (2 mg/o.d.)
Trial: 30913304
Drug: mFOLFOX6 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mFOLFOX6 plus ziv-aflibercept (4 mg/kg every 2 weeks)
Trial: 28163068
Drug: Hyaluronic Acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic Acid (HA) treatment on one side of the face
Trial: 28163068
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment on the other side of the face
Trial: 26759214
Drug: Alogliptin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin (25 mg once daily)
Trial: 24734338
Drug: Implant-link semi
RxNorm normalized name: Semi-Daonil
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant-link semi cement application
Trial: 20861750
Drug: Propionyl-L-carnitine (PLC)
RxNorm normalized name: glycine propionyl-L-carnitine
DrugBank: Levocarnitine propionate (DB15980)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (PLC) 2 g daily
Trial: 18302285
Drug: Debio‐025 (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debio‐025 (1200 mg twice daily for 14 days)
Trial: 17201845
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at sedative doses
Trial: 14627865
Drug: 50 microg
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 microg transdermal 17beta‐estradiol (tE2, n = 33)
Trial: 14627865
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oral 17beta‐estradiol (oE2, n = 37)
Trial: 14627865
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oral 17beta‐estradiol combined with 25 microg gestodene (oE2 + G, n = 33)
Trial: 10725476
Drug: Intravaginal indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal indomethacin (200 mg)
Trial: 10725476
Drug: Intrarectal plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrarectal plus oral indomethacin (200 mg)
Trial: 8504041
Drug: SPF 15+,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPF 15+, broad‐spectrum, water‐resistant sunscreen cream
Trial: 8504041
Drug: Cream base
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream base without active ingredients (Control)
Trial: 3551494
Drug: Guar diet
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar diet (5% of daily carbohydrate intake)
Trial: 3551494
Drug: Guar +
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar + fructose diet (1 g of fructose/kg body weight, max 30 g/d)
Trial: 21680251
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (n = 127)
Trial: 11083131
Drug: Melatonin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (5 mg day(‐1))
Trial: 8437068
Drug: Caudal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal bupivacaine 0.25%, 0.7 mL/kg
Trial: 3743795
Drug: Follicle aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follicle aspiration and CC use
Trial: 3743795
Drug: No CC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No CC treatment
Trial: 30025522
Drug: Magnesium (250
RxNorm normalized name: magnesium gluconate 12.5 mg magnesium (250 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (250 mg/day) plus Vitamin E (400 IU/day)
Trial: 27660192
Drug: Capecitabine plus
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine plus bevacizumab (16 cycles of 7.5 mg/kg bevacizumab by intravenous infusion over 90 min on day 1 of each cycle)
Trial: 27660192
Drug: Capecitabine alone
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine alone (1250 mg/m2 twice daily for 14 days followed by a break for 7 days for 8 cycles)
Trial: 24768895
Drug: MSG broth
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MSG broth (0.5 g/100 ml)
Trial: 24768895
Drug: MSG+ broth
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MSG+ broth (0.05 g/100 ml)
Trial: 24768895
Drug: Control preload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control preload (low-energy chicken flavor broth, 200 ml)
Trial: 22475864
Drug: 3.75 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 μg hemagglutinin antigen
Trial: 22475864
Drug: 7.5 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 μg hemagglutinin antigen
Trial: 20417423
Drug: Fentanyl, 1
RxNorm normalized name: FentaNYL, 100 mcg buccal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl, 1 microg/kg, and ketamine, 0.5 mg/kg (group FK)
Trial: 20417423
Drug: Fentanyl, 1
RxNorm normalized name: FentaNYL, 100 mcg buccal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl, 1 microg/kg, and normal saline solution (group F)
Trial: 18600492
Drug: Zinc-monocysteine (ZMC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc-monocysteine (ZMC) 25 mg twice daily
Trial: 12022177
Drug: Tea polyphenols
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea polyphenols (TP) 600 mg/d orally
Trial: 1376694
Drug: Acetorphan (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetorphan (200 mg)
Trial: 30719817
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine (0.1 mg kg-1 hr-1)
Trial: 29420994
Drug: l-Theanine
RxNorm normalized name: L-Theanine
DrugBank: Theanine (DB12444)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Theanine
Trial: 29420994
Drug: l-Theanine-Caffeine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Theanine-Caffeine combination
Trial: 25331395
Drug: Guided tissue
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided tissue regeneration and bone graft therapy
Trial: 20589924
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of caffeine
Trial: 12635747
Drug: highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: highly purified follicle stimulating hormone (pFSH)
Trial: 7579435
Drug: Streptokinase 1,500,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase 1,500,000 IU over 1 hour followed by a 48-hour placebo infusion
Trial: 7579435
Drug: Streptokinase 250,000
RxNorm normalized name: streptokinase 250,000 unit INTRAVEN VIAL (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase 250,000 IU over 1 hour followed by a continuous infusion of 100,000 IU per hour over 48 hours
Trial: 2010447
Drug: Diltiazem (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (10 mg/L in crystalloid potassium cardioplegia)
Trial: 6838742
Drug: Low-dose ketamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ketamine anaesthesia
Trial: 27060836
Drug: Subcutaneous peginterferon
RxNorm normalized name: peginterferon alfa-2a Injection [Pegasys]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous peginterferon beta‐1a (125 μg s.c.)
Trial: 27060836
Drug: Subcutaneous interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous interferon beta‐1a (44 μg s.c. three times per week)
Trial: 27060836
Drug: Subcutaneous peginterferon
RxNorm normalized name: peginterferon alfa-2a Injection [Pegasys]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous peginterferon beta‐1a
Trial: 22240389
Drug: Fast dissolving
RxNorm normalized name: Mucinex Sinus-Max Day/Night Fast Dissolving Gels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast dissolving oral film containing 4 mg dexamethasone
Trial: 22240389
Drug: Tablet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet containing 8 mg dexamethasone
Trial: 16965776
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg and placebo
Trial: 17483542
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg and Candesartan 16 mg
Trial: 17483542
Drug: Candesartan 16
RxNorm normalized name: candesartan 16 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 16 mg and placebo
Trial: 17483542
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Ramipril 10 mg and Candesartan 16 mg)
Trial: 17483542
Drug: Candesartan therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan therapy
Trial: 16305585
Drug: BMS‐193884 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS‐193884 (200 mg, oral)
Trial: 9794714
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment (placebo-controlled randomized trial)
Trial: 2706175
Drug: Orogastric tube
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orogastric tube followed by 30 ml of sodium citrate 0.3 mol litre‐1
Trial: 2706175
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml of sodium citrate 0.3 mol litre‐1
Trial: 2706175
Drug: Ranitidine 50
RxNorm normalized name: ranitidine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 50 mg i.v. before operation, in addition to sodium citrate
Trial: 31600833
Drug: bFGF related
RxNorm normalized name: bFGF
DrugBank: Basic Fibroblast Growth Factor (DB14131)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bFGF related decapeptide solution plus Tacrolimus 0.1% ointment (M + T)
Trial: 31600833
Drug: Tacrolimus 0.1%
RxNorm normalized name: TACROLIMUS 0.1% OINT,TOP
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus 0.1% ointment (T)
Trial: 24914429
Drug: School-based oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based oral health intervention programme with dental hygienists working 4 hours weekly for two years, including fluoride varnish treatments every 6 months.
Trial: 24160382
Drug: Intracameral triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracameral triamcinolone acetonide 0.5 mg
Trial: 24160382
Drug: Intracameral triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracameral triamcinolone acetonide 1.0 mg
Trial: 24160382
Drug: Intracameral triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracameral triamcinolone acetonide 2.0 mg
Trial: 17699190
Drug: Very low-protein
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low-protein diet with dietary supplements (study B)
Trial: 11369159
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl (median first dose 75 microg/h, median final dose 100 microg/h)
Trial: 11369159
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl (for > or =3 months until death)
Trial: 9164988
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg zinc gluconate/d for 15 days
Trial: 3653532
Drug: Ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 150 mg twice daily for 1 week